News Updates
More Articles
- Benefits of Integrating Patient Engagement with Diversity, Equity, and Inclusion in New Medical Product Development: A Call for Action
- Drug Shortages in the Global South: A Proposed Parallel Tech and Reg Transfer Framework
- Fair Pay for Patient Engagement: Navigating the Evolving Landscape of Remuneration
- Industry’s Window to Express Interest in Africa Continental Product Evaluation Pilot Closes End of February 2024
- Accelerating Adoption of eLabeling in Singapore: One Company’s Journey
Opportunities in 2021 to Fix the Broken Antibiotics Market
The US Centers for Disease Control and Prevention estimates at least 2.8 million antibiotic-resistant infections occur in the US annually, and more than 35,000 people die. At the same time, investments in new antibiotics to meet the threat are faltering, potentially reducing patient access to life-saving treatments.
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!